Gf Fund Management Co. Ltd. Avidity Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,961 shares of RNA stock, worth $209,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,961
Previous 2,768
6.97%
Holding current value
$209,638
Previous $121 Million
77.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RNA
# of Institutions
316Shares Held
139MCall Options Held
1.24MPut Options Held
545K-
Janus Henderson Group PLC London, X014.5MShares$1.03 Billion0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$966 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY11.4MShares$805 Million6.62% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$713 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.79MShares$693 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...